Microcatheter Market by Type (Delivery, Diagnostic, Aspiration, Steerable), Design (Single, Dual), Application (Cardiovascular, Neurovascular, Peripheral Vascular, Oncology), End-User (Hospital and Ambulatory Surgical Centers) - Global Forecasts to 2027
[164 Pages Report] The global microcatheter market is projected to reach USD 1,082 million by 2027 from USD 828 million in 2022, at a CAGR of 5.5% during the forecast period. This is attributed to the rising prevalence of cardiovascular and neurovascular diseases, an increasing number of invasive diagnostic and therapeutic procedures, and increased pharmaceutical and biotechnology industry research activities. Increasing sedentary lifestyle and advancements to replace open surgeries.
Global Microcatheter Market
e- Estimated; p- Projected
To know about the assumptions considered for the study, Request for Free Sample Report
Microcatheter Market: Market Dynamics
Driver: Growing adoption of minimally invasive procedures
The past decade saw a significant increase in the preference for minimally invasive and over traditional surgical procedures. The variety of tools and techniques, skilled surgeons and technicians today make minimally invasive procedures easy. Furthermore, minimally invasive/nonsurgical alternatives offer advantages over traditional surgical procedures, such as less pain, reduced scarring, and quicker recovery. Government funds and reimburesemnet policies is also driving patients to opt for minimally invasive procedures.
Opportunities: Emerging markets
Emerging countries such as APAC,Japan present significant opportunities for players operating in the microcatheter market. The demand for microcatheter market in these countries is increasing owing to rapid growth in medical tourism, the growing adult (aged 20 and above) population, increasing cardiovascular and neurovascular diseases. These countries are also home to a strong and qualified workforce and have a great knowledge of advance technologies.Furthermore, these countries have lenient policies for imports/exports and are underpenetrated in most aspects, which could help companies in brand development. Increasing developing technicians and the keen to know about new technologies is helping the regions to grow and update their technologies.
By product type, the delivery microcatheter segment accounted for the largest share during the forecast period.
In 2022, the delivery microcatheters segment accounted for the largest share of the microcatheters market in the US. This segment is projected to reach USD 442 million by 2027 from USD 332 million in 2022, at a CAGR of 5.9% during the forecast period.
Delivery microcatheters are easily available and easy to use as compared to other microcatheter. They work efficiently and have shown positive response in the indiviauls who are treated with delivery microcatheters.These microcatheters help to delivery diagnostic agents,such as contrast media and therapeutic agents,such as occlusion coils to peripheral and neuro vasculatures.
By End User Hospitals, the surgical centers and Specialty Clinics segment is expected to grow at the fastest rate during the forecast period.
In 2020, hospitals, surgical centers, & specialty clinics dominated the microcatheters market with a share of 72.8%. This end-user segment is projected to reach USD 799.5 million by 2027 from USD 548.5 million in 2020, at a CAGR of 5.7% during the forecast period. This end-user segment is also expected to grow at the highest CAGR of 5.7% during the forecast period. Growth in this segment is mainly due to the growing number of hospitals and specialty clinics in emerging countries; increasing prevalence of target diseases; and the growing number of cardiovascular, neurological, and oncological procedures. The ambulatory care centers segment is estimated to reach USD 283.5 million by 2027 from USD 202.3 million in 2020, at a CAGR of 5.1%.
North America is expected to be the largest market during the forecast period.
North America, comprising the US and Canada, accounted for the largest share of 46.4% of the microcatheters market in 2020. Factors such as the increasing number of target diagnostic and interventional procedures performed in the region, high prevalence of diseases, rising geriatric population, and the high market availability of advanced interventional products (including microcatheters) are driving the growth of the microcatheters market in North America.
To know about the assumptions considered for the study, download the pdf brochure
Key Market Players
As of 2021, prominent players in the market are Boston Scientific Corporation. (US), Stryker Corporation (US), Teleflex Incorporated (US), Cook Group (US), Becton Dickinson and Company (US), Asahi Intecc Co.ltd (Japan) among others.
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
Request Sample Scope of the Report
:
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
|
Report Metric |
Details |
|
Market size available for years |
20202027 |
|
Base year considered |
2021 |
|
Forecast period |
20222027 |
|
Forecast units |
Value (USD) |
|
Segments covered |
Product, End Use, and Region |
|
Geographies covered |
North America, Europe, Asia Pacific, Latin America, and Middle East and Africa |
|
Companies covered |
Boston Scientific Corporation. (US), Stryker Corporation (US), Teleflex Incorporated (US), Cook Group (US), Becton Dickinson and Company (US), Asahi Intecc Co.ltd (Japan), Terumo Medical Corporation (Japan), Medtronic (US), Teleflex Incorporated (US), Johnson & Johnson(US), Penumbra(US), Cardinal Health (US), Kaneka Corporation( Japan) |
This report has segmented the global microcatheters market based on product type, end user type, and region.
Global Microcatheters Market, by Product
- Delivery Microcatheter
- Aspiration Microcatheters
- Diagnostic Microccatheters
- Steerable Microcatheters
Global Microcatheters Market, by End User
- Hospitals, Surgical Centers & Specialty Clinics
- Ambulatory Care Centers
Microcatheters Market, by Region
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
Recent Developments
- In 2021, Terumo medical corporation introduced new microcatheter named PG Pro Peripheral Microcatheter.
- In 2020, Tri Saslus introduced new TriNav Microcatheter.
- In 2021, Pneumbra received US FDA approval for its RED 62 Reperfusiom catheter.
Frequently Asked Questions (FAQ):
What is the expected addressable market value of global microcatheter market over a 5-year period?
The global microcatheter market is projected to reach USD 1,082 million by 2027 from USD 828 million in 2022, at a CAGR of 5.5% during the forecast period.
Which segment based on application is expected to garner the highest traction within the microcatheter market?
The cardiovascular segment based on the application is witness to have the highest growth.
Which segment based on product & design is expected to garner the highest traction within the microcatheter market?
The delivery microcatheter product segment and single lumen microcatheter design segment is having the highest growth.
What are the strategies adopted by the top market players to penetrate emerging regions?
The major players in the market use partnerships, distribution agreements, product launches, and product approvals as important growth tactics
What are the major factors expected to limit the growth of the microcatheter?
Stringent regulatory scenario, product pricing, and establishing a market presence. Social and ethical issues associated with cosmetic treatments are key challenges faced by the market. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 24)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 MICROCATHETERS MARKET, BY SEGMENTATION
FIGURE 2 MICROCATHETERS MARKET, BY REGION
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 28)
2.1 RESEARCH DATA
2.2 RESEARCH DESIGN
FIGURE 3 MICROCATHETERS MARKET: RESEARCH DESIGN
2.2.1 SECONDARY DATA
2.2.2 PRIMARY DATA
FIGURE 4 PRIMARY SOURCES
2.2.2.1 Key data from primary sources
2.2.2.2 Insights from primary experts
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
FIGURE 7 SUPPLY SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 8 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.5 MARKET SHARE ESTIMATION
2.6 RESEARCH ASSUMPTIONS
2.7 STUDY LIMITATIONS
2.7.1 METHODOLOGY-RELATED LIMITATIONS
2.8 RISK ASSESSMENT
TABLE 1 LIMITATIONS AND ASSOCIATED RISKS
3 EXECUTIVE SUMMARY (Page No. - 37)
FIGURE 10 MICROCATHETERS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 11 MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2022 VS. 2027 (USD MILLION)
FIGURE 12 MICROCATHETERS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 13 MICROCATHETERS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 14 ASIA PACIFIC MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
4 PREMIUM INSIGHTS (Page No. - 41)
4.1 MICROCATHETERS MARKET OVERVIEW
FIGURE 15 TECHNOLOGICAL ADVANCEMENTS AND RISING CHRONIC DISEASE INCIDENCE TO DRIVE DEMAND
4.2 MICROCATHETERS MARKET SHARE, BY COUNTRY AND PRODUCT
FIGURE 16 NORTH AMERICA TO HOLD LARGEST SHARE OF GLOBAL MARKET
4.3 MICROCATHETERS MARKET SHARE, BY END USER
FIGURE 17 HOSPITALS TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD
4.4 GEOGRAPHICAL SNAPSHOT OF MICROCATHETERS MARKET
FIGURE 18 INDIA TO GROW AT HIGHEST RATE DURING 20222027
5 MARKET OVERVIEW (Page No. - 44)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 MICROCATHETERS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
5.2.1 DRIVERS
5.2.1.1 Technological advancements in interventional cardiology
5.2.1.2 Expansion of patient population suffering from chronic illness
5.2.1.3 Increasing conferences and symposia to spread awareness about benefits of microcatheters
5.2.2 RESTRAINTS
5.2.2.1 Stringent regulatory guidelines and high cost of drug approval
5.2.2.2 Lack of awareness about microcatheters in underdeveloped or emerging countries
5.2.3 OPPORTUNITIES
5.2.3.1 Rising number of patients suffering from chronic diseases and cancer globally
5.3 KEY STAKEHOLDERS AND BUYING CRITERIA
5.3.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MICROCATHETERS MARKET
TABLE 2 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR MICROCATHETERS MARKET
5.4 PORTERS FIVE FORCES ANALYSIS
5.4.1 OVERVIEW
TABLE 3 MICROCATHETERS MARKET: PORTERS FIVE FORCES ANALYSIS
5.4.2 THREAT OF NEW ENTRANTS
5.4.3 THREAT OF SUBSTITUTES
5.4.4 BARGAINING POWER OF SUPPLIERS
5.4.5 BARGAINING POWER OF BUYERS
5.4.6 DEGREE OF COMPETITION
5.5 REGULATORY ANALYSIS
5.5.1 US
TABLE 4 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.5.2 EUROPE
5.5.3 JAPAN
TABLE 5 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.6 REIMBURSEMENT ANALYSIS
TABLE 6 CPT CODES FOR MAJOR MICROCATHETERS
5.7 ECOSYSTEM ANALYSIS
5.8 VALUE CHAIN ANALYSIS
5.8.1 RESEARCH AND DEVELOPMENT
5.8.2 PROCUREMENT AND PRODUCT DEVELOPMENT
5.8.3 MARKETING, SALES & DISTRIBUTION, AND POST-SALES SERVICES
FIGURE 21 VALUE CHAIN ANALYSIS
5.9 SUPPLY CHAIN ANALYSIS
5.9.1 PROMINENT COMPANIES
5.9.2 SMALL & MEDIUM-SIZED COMPANIES
5.9.3 END USERS
FIGURE 22 SUPPLY CHAIN ANALYSIS
5.10 PATENT ANALYSIS
5.11 TRADE ANALYSIS
TABLE 7 IMPORT DATA FOR MICROCATHETERS (HS CODE 9018), BY COUNTRY, 20202022 (USD MILLION)
TABLE 8 EXPORT DATA FOR MICROCATHETERS (HS CODE 9018), BY COUNTRY, 20202022 (USD MILLION)
5.12 KEY CONFERENCES AND EVENTS IN 20222023
TABLE 9 MICROCATHETERS MARKET: DETAILED LIST OF MAJOR CONFERENCES AND EVENTS
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS BUSINESSES
FIGURE 23 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX
6 MICROCATHETER MARKET, BY PRODUCT (Page No. - 58)
6.1 INTRODUCTION
TABLE 10 MICROCATHETERS MARKET, BY PRODUCT, 20202027 (USD MILLION)
TABLE 11 MICROCATHETERS MARKET, BY APPLICATION, 20202027 (USD MILLION)
TABLE 12 MICROCATHETERS MARKET, BY END USER, 20202027 (USD MILLION)
TABLE 13 MICROCATHETERS MARKET, BY PRODUCT DESIGN, 20202027 (USD MILLION)
6.2 DELIVERY MICROCATHETERS
6.2.1 INCREASED NUMBER OF TARGET INTERVENTIONAL PROCEDURES TO DRIVE MARKET
TABLE 14 DELIVERY MICROCATHETERS MARKET, BY REGION, 20202027 (USD MILLION)
TABLE 15 DELIVERY MICROCATHETERS MARKET, BY PRODUCT DESIGN, 20202027 (USD MILLION)
TABLE 16 DELIVERY MICROCATHETERS MARKET, BY APPLICATION, 20202027 (USD MILLION)
TABLE 17 DELIVERY MICROCATHETERS MARKET, BY END USER, 20202027 (USD MILLION)
6.3 ASPIRATION MICROCATHETERS
6.3.1 INCREASING BURDEN OF CARDIOVASCULAR DISEASES AND RELATED MEDICAL PROCEDURES TO AUGMENT MARKET
TABLE 18 ASPIRATION MICROCATHETERS MARKET, BY REGION, 20202027 (USD MILLION)
TABLE 19 ASPIRATION MICROCATHETERS MARKET, BY PRODUCT DESIGN, 20202027 (USD MILLION)
TABLE 20 ASPIRATION MICROCATHETERS MARKET, BY APPLICATION, 20202027 (USD MILLION)
TABLE 21 ASPIRATION MICROCATHETERS MARKET, BY END USER, 20202027 (USD MILLION)
6.4 DIAGNOSTICS MICROCATHETERS
6.4.1 LARGE PATIENT POPULATION FOR VASCULAR DISEASES TO AID MARKET
TABLE 22 DIAGNOSTIC MICROCATHETERS MARKET, BY REGION, 20202027 (USD MILLION)
TABLE 23 DIAGNOSTIC MICROCATHETERS MARKET, BY PRODUCT DESIGN, 20202027 (USD MILLION)
TABLE 24 DIAGNOSTIC MICROCATHETERS MARKET, BY APPLICATION, 20202027 (USD MILLION)
TABLE 25 DIAGNOSTIC MICROCATHETERS MARKET, BY END USER, 20202027 (USD MILLION)
6.5 STEERABLE MICROCATHETERS
6.5.1 GROWING NUMBER OF IMAGE-GUIDED AND MINIMALLY INVASIVE MEDICAL PROCEDURES TO BOOST MARKET
TABLE 26 STEERABLE MICROCATHETERS MARKET, BY REGION, 20202027 (USD MILLION)
TABLE 27 STEERABLE MICROCATHETERS MARKET, BY PRODUCT DESIGN, 20202027 (USD MILLION)
TABLE 28 STEERABLE MICROCATHETERS MARKET, BY APPLICATION, 20202027 (USD MILLION)
TABLE 29 STEERABLE MICROCATHETERS MARKET, BY END USER, 20202027 (USD MILLION)
7 MICROCATHETERS MARKET, BY PRODUCT DESIGN (Page No. - 69)
7.1 INTRODUCTION
TABLE 30 MICROCATHETERS MARKET, BY PRODUCT DESIGN, 20202027 (USD MILLION)
7.2 SINGLE LUMEN MICROCATHETERS
7.2.1 INCREASING NUMBER OF TARGET MEDICAL PROCEDURES AND OPERATIONAL ADVANTAGES TO PROPEL MARKET
TABLE 31 SINGLE LUMEN MICROCATHETERS MARKET, BY REGION, 20202027 (USD MILLION)
7.3 DUAL-LUMEN MICROCATHETERS
7.3.1 PRODUCT ADVANTAGES AND INCREASED ADOPTION OF CATHETERS TO DRIVE MARKET
TABLE 32 DUAL-LUMEN MICROCATHETERS MARKET, BY REGION, 20202027 (USD MILLION)
8 MICROCATHETERS MARKET, BY APPLICATION (Page No. - 73)
8.1 INTRODUCTION
TABLE 33 MICROCATHETERS MARKET, BY APPLICATION, 20202027 (USD MILLION)
8.2 CARDIOVASCULAR APPLICATIONS
8.2.1 PROCEDURAL BENEFITS DURING CRITICAL CARDIAC SURGERIES TO AID MARKET
TABLE 34 MICROCATHETERS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 20202027 (USD MILLION)
8.3 NEUROVASCULAR APPLICATIONS
8.3.1 INCREASING INCIDENCE OF TARGET NEUROLOGICAL CONDITIONS TO DRIVE MARKET
TABLE 35 MICROCATHETERS MARKET FOR NEUROVASCULAR APPLICATIONS, BY REGION, 20202027 (USD MILLION)
8.4 PERIPHERAL VASCULAR APPLICATION
8.4.1 RISING TARGET DIAGNOSTIC AND INTERVENTIONAL PROCEDURES TO STIMULATE MARKET
TABLE 36 MICROCATHETERS MARKET FOR PERIPHERAL VASCULAR APPLICATIONS, BY REGION, 20202027 (USD MILLION)
8.5 ONCOLOGY APPLICATIONS
8.5.1 INCREASING CLINICAL RESEARCH ON MINIMALLY INVASIVE CANCER TREATMENT TO DRIVE MARKET
TABLE 37 MICROCATHETERS MARKET FOR ONCOLOGY APPLICATIONS, BY REGION, 20202027 (USD MILLION)
9 MICROCATHETERS MARKET, BY END USER (Page No. - 79)
9.1 INTRODUCTION
TABLE 38 MICROCATHETERS MARKET, BY END USER, 20202027 (USD MILLION)
9.2 HOSPITALS, SURGICAL CENTERS, AND SPECIALTY CLINICS
9.2.1 LARGE NUMBER OF SURGICAL AND DIAGNOSTIC PROCEDURES TO PROPEL MARKET
TABLE 39 MICROCATHETERS MARKET FOR HOSPITALS, SURGICAL CENTERS, AND SPECIALTY CLINICS, BY REGION, 20202027 (USD MILLION)
9.3 AMBULATORY CARE CENTERS
9.3.1 LIMITED SURGICAL CAPABILITIES OF AVAILABLE PRODUCTS TO RESTRAIN ADOPTION
TABLE 40 MICROCATHETERS MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 20202027 (USD MILLION)
10 MICROCATHETERS MARKET, BY REGION (Page No. - 83)
10.1 INTRODUCTION
TABLE 41 MICROCATHETERS MARKET, BY REGION, 20202027 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 24 NORTH AMERICA: MARKET SNAPSHOT
TABLE 42 NORTH AMERICA: MICROCATHETERS MARKET, BY COUNTRY, 20202027 (USD MILLION)
TABLE 43 NORTH AMERICA: MICROCATHETERS MARKET, BY PRODUCT, 20202027 (USD MILLION)
TABLE 44 NORTH AMERICA: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 20202027 (USD MILLION)
TABLE 45 NORTH AMERICA: MICROCATHETERS MARKET, BY APPLICATION, 20202027 (USD MILLION)
TABLE 46 NORTH AMERICA: MICROCATHETERS MARKET, BY END USER, 20202027 (USD MILLION)
10.2.1 US
10.2.1.1 US to dominate North American market during forecast period
TABLE 47 US: MICROCATHETERS MARKET, BY PRODUCT, 20202027 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Increasing prevalence of target diseases and high demand for timely diagnosis to propel market
TABLE 48 CANADA: MICROCATHETERS MARKET, BY PRODUCT, 20202027 (USD MILLION)
10.3 EUROPE
TABLE 49 EUROPE: MICROCATHETERS MARKET, BY COUNTRY, 20202027 (USD MILLION)
TABLE 50 EUROPE: MICROCATHETERS MARKET, BY PRODUCT, 20202027 (USD MILLION)
TABLE 51 EUROPE: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 20202027 (USD MILLION)
TABLE 52 EUROPE: MICROCATHETERS MARKET, BY APPLICATION, 20202027 (USD MILLION)
TABLE 53 EUROPE: MICROCATHETERS MARKET, BY END USER, 20202027 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Increasing aging population and rising life expectancy to boost market
TABLE 54 GERMANY: MICROCATHETERS MARKET, BY PRODUCT, 20202027 (USD MILLION)
10.3.2 FRANCE
10.3.2.1 Significant evolution of healthcare sector to drive market
TABLE 55 FRANCE: MICROCATHETERS MARKET, BY PRODUCT, 20202027 (USD MILLION)
10.3.3 UK
10.3.3.1 High burden of chronic diseases and large volume of surgeries to augment market
TABLE 56 UK: MICROCATHETERS MARKET, BY PRODUCT, 20202027 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Increasing geriatric population to aid growth
TABLE 57 ITALY: MICROCATHETERS MARKET, BY PRODUCT, 20202027 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Increasing technological developments in healthcare sector to propel market
TABLE 58 SPAIN: MICROCATHETERS MARKET, BY PRODUCT, 20202027 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 59 REST OF EUROPE: MICROCATHETERS MARKET, BY PRODUCT, 20202027 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 25 ASIA PACIFIC: MARKET SNAPSHOT
TABLE 60 ASIA PACIFIC: MICROCATHETERS MARKET, BY COUNTRY, 20202027 (USD MILLION)
TABLE 61 ASIA PACIFIC: MICROCATHETERS MARKET, BY PRODUCT, 20202027 (USD MILLION)
TABLE 62 ASIA PACIFIC: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 20202027 (USD MILLION)
TABLE 63 ASIA PACIFIC: MICROCATHETERS MARKET, BY APPLICATION, 20202027 (USD MILLION)
TABLE 64 ASIA PACIFIC: MICROCATHETERS MARKET, BY END USER, 20202027 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 Increasing geriatric population and surgical procedures to drive market
TABLE 65 JAPAN: MICROCATHETERS MARKET, BY PRODUCT, 20202027 (USD MILLION)
10.4.2 CHINA
10.4.2.1 Growing prevalence of chronic disorders and developing healthcare infrastructure to aid growth
TABLE 66 CHINA: MICROCATHETERS MARKET, BY PRODUCT, 20202027 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Increasing target patient population with rising availability of advanced surgical treatments to drive market
TABLE 67 INDIA: MICROCATHETERS MARKET, BY PRODUCT, 20202027 (USD MILLION)
10.4.4 AUSTRALIA
10.4.4.1 Developing healthcare sector and increasing availability of advanced surgical treatments to stimulate market
TABLE 68 AUSTRALIA: MICROCATHETERS MARKET, BY PRODUCT, 20202027 (USD MILLION)
10.4.5 SOUTH KOREA
10.4.5.1 Growing target patient population for cardiovascular diseases to drive market
TABLE 69 SOUTH KOREA: MICROCATHETERS MARKET, BY PRODUCT, 20202027 (USD MILLION)
10.4.6 REST OF ASIA PACIFIC
TABLE 70 REST OF ASIA PACIFIC: MICROCATHETERS MARKET, BY PRODUCT, 20202027 (USD MILLION)
10.5 LATIN AMERICA
10.5.1 FAVORABLE ECOSYSTEM FOR MEDICAL EQUIPMENT AND SUPPLIES TO DRIVE MARKET
TABLE 71 LATIN AMERICA: MICROCATHETERS MARKET, BY COUNTRY, 20202027 (USD MILLION)
TABLE 72 LATIN AMERICA: MICROCATHETERS MARKET, BY PRODUCT, 20202027 (USD MILLION)
TABLE 73 LATIN AMERICA: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 20202027 (USD MILLION)
TABLE 74 LATIN AMERICA: MICROCATHETERS MARKET, BY APPLICATION, 20202027 (USD MILLION)
TABLE 75 LATIN AMERICA: MICROCATHETERS MARKET, BY END USER, 20202027 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 INCREASING FOCUS OF MARKET PLAYERS TO ESTABLISH THEIR PRESENCE TO PROPEL MARKET
TABLE 76 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY PRODUCT, 20202027 (USD MILLION)
TABLE 77 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 20202027 (USD MILLION)
TABLE 78 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY APPLICATION, 20202027 (USD MILLION)
TABLE 79 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY END USER, 20202027 (USD MILLION)
11 COMPETITIVE LANDSCAPE (Page No. - 107)
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
FIGURE 26 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MICROCATHETERS MARKET
11.3 MARKET RANKING ANALYSIS
FIGURE 27 MICROCATHETERS MARKET (2021)
11.3.1 BOSTON SCIENTIFIC CORPORATION
11.3.2 ASAHI INTECC CO., LTD.
11.3.3 MEDTRONIC PLC
11.3.4 TELEFLEX
11.3.5 TERUMO MEDICAL CORPORATION
11.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 28 REVENUE ANALYSIS OF KEY PLAYERS IN MICROCATHETERS MARKET
11.5 COMPETITIVE BENCHMARKING OF TOP 26 PLAYERS
TABLE 80 OVERALL FOOTPRINT OF COMPANIES
TABLE 81 PRODUCT FOOTPRINT OF COMPANIES (26 COMPANIES)
TABLE 82 END USER FOOTPRINT OF COMPANIES (26 COMPANIES)
TABLE 83 REGIONAL FOOTPRINT OF COMPANIES (26 COMPANIES)
11.6 COMPANY EVALUATION QUADRANT
11.6.1 STARS
11.6.2 EMERGING LEADERS
11.6.3 PERVASIVE PLAYERS
11.6.4 PARTICIPANTS
FIGURE 29 MICROCATHETERS MARKET: COMPETITIVE LEADERSHIP MAPPING (2021)
11.7 START-UPS/SMES EVALUATION QUADRANT
11.7.1 PROGRESSIVE COMPANIES
11.7.2 DYNAMIC COMPANIES
11.7.3 STARTING BLOCKS
11.7.4 RESPONSIVE COMPANIES
FIGURE 30 MICROCATHETERS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2021)
11.8 COMPETITIVE SCENARIO
11.8.1 PRODUCT LAUNCHES AND APPROVALS
TABLE 84 PRODUCT LAUNCHES AND APPROVALS, 20192022
11.8.2 ALLIANCES, PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
TABLE 85 ALLIANCES, PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS, 20192022
12 COMPANY PROFILES (Page No. - 122)
(Business Overview, Products/Services/Solutions offered, MnM view, Key strengths/right to win, Strategic choices made, Weakness/competitive threats)*
12.1 KEY PLAYERS
12.1.1 BOSTON SCIENTIFIC CORPORATION
TABLE 86 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
FIGURE 31 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2021)
12.1.2 ASAHI INTECC CO., LTD.
TABLE 87 ASAHI INTECC CO., LTD: COMPANY OVERVIEW
FIGURE 32 ASAHI INTECC CO., LTD.: COMPANY SNAPSHOT (2021)
12.1.3 MEDTRONIC PLC
TABLE 88 MEDTRONIC PLC: COMPANY OVERVIEW
FIGURE 33 MEDTRONIC PLC.: COMPANY SNAPSHOT (2021)
12.1.4 STRYKER
TABLE 89 STRYKER: COMPANY OVERVIEW
FIGURE 34 STRYKER: COMPANY SNAPSHOT (2021)
12.1.5 BECTON, DICKINSON AND COMPANY
TABLE 90 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
FIGURE 35 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2021)
12.1.6 TERUMO MEDICAL CORPORATION
TABLE 91 TERUMO MEDICAL CORPORATION: COMPANY OVERVIEW
FIGURE 36 TERUMO MEDICAL CORPORATION: COMPANY SNAPSHOT (2021)
12.1.7 MERIT MEDICAL SYSTEMS, INC.
TABLE 92 MERIT MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW
FIGURE 37 MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2021)
12.1.8 CARDINAL HEALTH
TABLE 93 CARDINAL HEALTH: COMPANY OVERVIEW
FIGURE 38 CARDINAL HEALTH: COMPANY SNAPSHOT (2021)
12.1.9 B. BRAUN MELSUNGEN AG
TABLE 94 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW
12.1.10 COOK MEDICAL GROUP
TABLE 95 COOK MEDICAL GROUP: COMPANY OVERVIEW
12.1.11 TELEFLEX
TABLE 96 TELEFLEX: COMPANY OVERVIEW
12.1.12 JOHNSON & JOHNSON
TABLE 97 JOHNSON & JOHNSON: COMPANY OVERVIEW
12.1.13 ANGIODYNAMICS
TABLE 98 ANGIODYNAMICS: COMPANY OVERVIEW
12.1.14 PENUMBRA
TABLE 99 PENUMBRA: COMPANY OVERVIEW
12.1.15 BTG PLC
TABLE 100 BTG PLC: COMPANY OVERVIEW
12.1.16 GUERBET LLC
TABLE 101 GUERBET LLC: COMPANY OVERVIEW
12.1.17 EMBOLX INC.
TABLE 102 EMBOLX INC.: COMPANY OVERVIEW
12.1.18 TOKAI MEDICAL
TABLE 103 TOKAI MEDICAL: COMPANY OVERVIEW
12.1.19 KANEKA CORPORATION
TABLE 104 KANEKA CORPORATION.: COMPANY SNAPSHOT
12.1.20 INTEGER HOLDINGS CORPORATION
TABLE 105 INTEGER HOLDINGS CORPORATION: COMPANY OVERVIEW
12.1.21 LIBATAPE PHARMACEUTICAL CO., LTD.
TABLE 106 LIBATAPE PHARMACEUTICAL CO., LTD.: COMPANY OVERVIEW
12.1.22 MICROVENTION TERUMO
TABLE 107 MICROVENTION TERUMO: COMPANY OVERVIEW
12.1.23 REFLOW MEDICAL
TABLE 108 REFLOW MEDICAL: COMPANY OVERVIEW
12.1.24 SPARTAN MICRO
TABLE 109 SPARTAN MICRO: COMPANY OVERVIEW
12.1.25 TRANSIT SCIENTIFIC
TABLE 110 TRANSIT SCIENTIFIC: COMPANY OVERVIEW
12.1.26 TRISALUS LIFE SCIENCES, INC.
TABLE 111 TRISALUS LIFE SCIENCES, INC.: COMPANY OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, Deals, MnM view, Key strengths/right to win, Strategic choices made, Weakness/competitive threats might not be captured in case of unlisted companies.
13 APPENDIX (Page No. - 163)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
Secondary Research
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the microcatheter market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the Microcatheter Market. The primary sources from the demand side include medical OEMs, Oncologists, CDMOs and service providers, among others. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.
A breakdown of the primary respondents is provided below:
*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note: Companies are classified into tiers based on their total revenue. As of 2019, Tier 1 = >USD 1,000 million, Tier 2 = USD 5001,000 million, and Tier 3 = To know about the assumptions considered for the study, download the pdf brochure In this report, the microcatheter market's size was arrived at by using the revenue share analysis of leading players. For this purpose, key players in the market were identified, and their revenues from the microcatheters business were determined through various insights gathered during the primary and secondary research phases. Secondary research included the study of the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, such as CEOs, directors, and key marketing executives. To calculate the global market value, segmental revenues were calculated based on the revenue mapping of major solution/service providers. This process involved the following steps: To know about the assumptions considered for the study, Request for Free Sample Report After arriving at the overall market size from the market size estimation process explained above, the global microcatheter market was split into segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the microcatheter market was validated using both top-down and bottom-up approaches. With the given market data, MarketsandMarkets offers customizations as per the companys specific needs. The following customization options are available for the present global microcatheter report:Market Estimation Methodology
Data Triangulation
Objectives of the Study
Available Customizations
Product Analysis
Company Information
Geographic Analysis
Growth opportunities and latent adjacency in Microcatheter Market